$RXST SEC Filings

Filed On	Filing
16 Sep 2026	Form 4: Weinberg Eric, See remarks Received 35,168 shares by exercise or conversion ($153K)
09 Sep 2026	Form 4: Wilterding Mark, Chief Financial Officer Disposed of 258,770 Stock Option (right to buy) (Disposition to Issuer) · Granted 258,770 Stock Option (right to buy)
09 Sep 2026	Form 4: Weinberg Eric, See remarks Disposed of 87,437 Stock option (right to buy) (Disposition to Issuer) · Disposed of 362,200 Stock Option (right to buy) (Disposition to Issuer) · Granted 334,075 Stock Option (right to buy)
09 Sep 2026	Form 4: Kurtz Ronald M Md, Chief Medical Officer Disposed of 338,819 Stock option (right to buy) (Disposition to Issuer) · Disposed of 564,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 686,447 Stock Option (right to buy)
09 Sep 2026	Form 4: Goldshleger Ilya, Chief Operating Officer Disposed of 98,367 Stock option (right to buy) (Disposition to Issuer) · Disposed of 387,200 Stock Option (right to buy) (Disposition to Issuer) · Granted 364,032 Stock Option (right to buy)
08 Sep 2026	SC TO-I/A
02 Sep 2026	144
02 Sep 2026	144
02 Sep 2026	144
02 Sep 2026	144
02 Sep 2026	Form 4: Kurtz Ronald M Md, Chief Medical Officer Received 13,425 shares by exercise or conversion · Sold 5,100 shares ($35.5K)
02 Sep 2026	Form 4: Wilterding Mark, Chief Financial Officer Received 20,441 shares by exercise or conversion · Sold 7,765 shares ($54K)
02 Sep 2026	Form 4: Goldshleger Ilya, Chief Operating Officer Received 5,370 shares by exercise or conversion · Sold 2,041 shares ($14.2K)
02 Sep 2026	Form 4: Weinberg Eric, See remarks Received 5,370 shares by exercise or conversion · Sold 2,041 shares ($14.2K)
25 Aug 2026	SC TO-I/A
19 Aug 2026	SCHEDULE 13G
18 Aug 2026	144
10 Aug 2026	SC TO-I
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition

Comments